Loading provider…
Loading provider…
Neurology Physician in Houston, TX
NPI: 1124009113Primary Practice Location
THE METHODIST HOSPITAL SNF
6565 FANNIN, Houston, TX
Primary Employer
Tmh Physician Associates PLLC
houstonmethodist.org
HQ Phone
Get M.D. Stanley's Phone NumberMobile
Get M.D. Stanley's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1977 - 2027
NC State Medical License
1967 - 1982

American Board of Psychiatry and Neurology
Neurology
University of Pennsylvania Health System
Residency • Neurology
1965 - 1966
Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
Residency • Neurology
1961 - 1962
Mass General Brigham/Massachusetts General Hospital
Internship • Internal Medicine
1960 - 1961
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 1960
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 50 | 51 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 36 | 36 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 15 | 17 |
Predictability of disease progression in amyotrophic lateral sclerosis
Authors: Ericka Greene
Journal: Muscle Nerve
Experimental autoimmune nigral damage in guinea pigs
Authors: Le, W D, Engelhardt, J, Xie, W J, Schneider, L, Smith, R G, Appel, S H
Journal: J Neuroimmunol
Lead Sponsor: The Methodist Hospital Research Institute
Collaborators: Massachusetts General Hospital, The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston, North East Amyotrophic Lateral Sclerosis Consortium
Intervention / Treatment: BIOLOGICAL: Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections, OTHER: Monthly placebo infusions + 3 times per week placebo injections
Lead Sponsor: Columbia University
Collaborators: Biogen, ALS Association